Call
International care teamChoose the line nearest you
Thailand+66 808 069 391UK & Europe+44 20 3286 1444Canada & USA+1-347-450-THAI (8424)Australia & New Zealand+61 (27) 908-9664
Get started
Regeneration Center

Dr Kampon Sriwatanakul MD PhD

Clinical context, institutional information and evidence from the Regeneration Center.

Stem Cell Regeneration CenterBangkok, Thailand
Published

Dr Kampon Sriwatanakul portrait, unverified draft for editorial review

Medical Degree:

  • B.Sc. 1972 Mahidol University Medical Science
  • M.D. 1974 Mahidol University Medicine (with Honors)
  • Ph.D. 1978 Mahidol University Pharmacology

Present Posts:

Previous Medical Posts

  • Ramathibodi Hospital : April 1974 – April 1975 – Lecturer, Department of Pharmacology, Faculty of Science
  • Mahidol University : May 1975 – August 1979 – Assistant Professor, Department of Pharmacology, Faculty of Science
  • Mahidol University : August 1979 – July 1985 – Chairman, Department of Pharmacology, Faculty of Science
  • Mahidol University : April 1984 – March 1988 – Director, Toxicology Graduate Program
  • Faculty of Graduate Studies, Mahidol University – June 1984 – January 1989
  • Deputy Dean, Faculty of Graduate Studies, Mahidol University August 1988 – January 1989
  • Assistant to the President on Foreign Relations and Research – Mahidol University : February 1989 – April 1990
  • Vice President on Research and Foreign Relations, Mahidol University – May 1990 – December 1991
  • Deputy Dean, Faculty of Graduate Studies, Mahidol University – January 1992 – April 1995

Other Institutional Posts :

  • Adjunct Scholar, Centre for the Study of Drug Development – Tufts University, Boston, USA
  • Member, The Medical Association of Thailand
  • Member, The Pharmacological and Therapeutic Society of Thailand
  • Member, The Toxicological Society of Thailand

Academic and Research Awards :

  • British Council Research Fellow in Pharmacology – University of Leicester, Leicester, UK – September 1978 – July 1979
  • Merck International Fellow in Clinical Pharmacology – University of Rochester, Rochester, New York, USA – January 1981 – December 1982
  • British Council Visiting Scientist – Department of Clinical Pharmacology
  • University of Edinburgh, Edinburgh, UK – December 1987 – June 1988
  • UICC : Yamagiwa-Yoshisa Memorial International Cancer Study Grants
  • Institute of Cancer Research – The Royal Marsden Hospital, Sutton, UK – November 1988 – January 1989

Current Research Interests :

  • Clinical Trials of New Pharmacokinetics
  • Clinical Pharmacokinetics
  • Development of Traditional Thai Herbal Medications
  • Pharmacoepidemiology
  • Neuromuscular Disorders

 

Previous Medical Journal,Publications and Communications :

1. Nahorski, SR and SRIWATANAKUL, K (1979) Analysis of the activity and distribution of beta-adrenoceptor antagonists using an ex vivo receptor binding assay. (Proceedings) Br. J. Pharmacol. 67: 415P

2. SRIWATANAKUL, Kamol and Nahorski, SR (1980) Disposition and activity of beta-adrenoceptor antagonists using an ex-vivo receptor binding assy. Eur. J. Pharmacol. 66: 169-178 [1]

3. SRIWATANAKUL, K and Weintraub, M (1981) Analgesic use in the treatment of cancer pain. Thai Cancer J. 7: 111-116

4. SRIWATANAKUL, K (1981) Lowering of seizure threshold induced by phenothiazine therapy. Thai J. Pharmacol. 3: 95-100

5. Weis, O and SRIWATANAKUL, K (1982) Methotrimeprazine analgesia. Drug Therapy. 12: 143-147

6. SRIWATANAKUL, K and Weintraub, M (1982) Food-drug interaction: an overlooked clinical problem. Drug Therapy. 12: 157-159 [2]

7. SRIWATANAKUL, K (1982) Minimizing the risk of antipsychotic associated seizures. Drug Therapy. 12: 207-250 OrcID

8. SRIWATANAKUL, K and Weis, O (1982) Using antipsychotic medications during pregnancy. Drug Therapy. 12: 247-250 [3]

9. Weis, O, SRIWATANAKUL, K. and Weintraub, M (1982) Methotrimeprazine in acute porpyria. South African Med. J. 61: 985-986

10. Weis, O, SRIWATANAKUL, K and Weintraub, M (1982) Treatment of post-herpetic neuralgia and acute herpetic pain with amitryptyline and perphenazine. South African Med. J. 62: 274-275

11. Calimlim, JF, Wardell, WM, SRIWATANAKUL, K, Lasagna, L and Cox, C (1982) Analgesic efficacy of parenteral metkephamid acetate in the treatment of postoperative pain. Lancet 1: 1374-1375

12. SRIWATANAKUL, K, Kelvin, W and Lasagna, L (1982) The quantification of pain : an analysis of words used to describe pain and analgesia in clinical trials. Clin. Pharmacol Ther. 32: 143-148

13. SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 17-35 [4]

14. SRIWATANAKUL, K (1982) A critical examination of drug interactions. Thai J. Pharmacol. 4: 143-151 [5]

15. SRIWATANAKUL, K and Weintraub, M (1983) Understanding food-drug interactions. Comprehensive Therapy. 9: 6-11

16. Weis, OF, SRIWATANAKUL, K, Alioza, JL Weintraub, M and Lasagna, L (1983) Attitudes of patients, housestaff and nurses towards post-operative analgesic care. Anesth. Anlgesia. 62: 70-74 [6]

17. Weis, OF SRIWATANAKUL, K. Weintraub, M and Lasagna, L (1983) Reduction of anxiety and postoperative analgesic requirements by audiovisual instruction. Lancet 1: 43-44 [7]

18. Weintraub, M, SRIWATANAKUL, K, Sundaresan, PR, Weis, OF and Dorn, M (1983) Extended-release fenfluramine: patient acceptance and efficacy f evening dosing. Clin. Pharmacol. Ther. 33: 621-627

19. SRIWATANAKUL, K and Mehta, G (1983) Update review of clinically significant drug interactions. Drug Therapy. 13” 41-44

20. Wang, ZX and SRIWATANAKUL, K (1983) Medications used for the treatment of dementia. Rational Drug Therapy.17: 1-4

21. SRIWATANAKUL, K, Kelvin, W, Lasagna, L, Calimlim, JF, Weis, OF and Mehta, G (1983) Studies with different types of visual analog scales for measurement of pain. Clin. Pharmacol. Ther. 34: 234-239 [8]

22. SRIWATANAKUL, K, lasagna, 1 and Cox, C (1983) Evaluation of current clinical trial methodology in analgesimetry based on experts opinions and analysis of several analgesic studies. Clin. Pharmacol. Ther.34: 277-283 [9]

23. SRIWATANAKUL, K (1983) Long-term follow-up of a clinical trial of anorexiant Medications. Thai J. Pharmacol. 5: 163-172

24. SRIWATANAKUL, K, Weis, OF, Allozo, JL, Keivn, W, Weintraub, M and Lasagna, L (1983).

25. Makarananda, K and SRIWATANAKUL, K (1983) Cancer chemotherapy : Drug interaction. Thai Cancer J. 9: 55-59

26. Pothisiri, P, Makarananda, K, SRIWATANAKUL, K, Chroonroj, P, Pongprayoon, U and Eamungroj, S (1984)Prospective study of adverse reactions of antiepileptic Medications in Thai outpatients. Thai J. Pharmacol. 6: 1-10

27. Makarananda, K, SRIWATANAKUL, K, Pothsiri, P, Eamrungroj, S, Charoonroj, P and Pongprayoon, U (1985)Prospective study of adverse drug reactions of antihypertensive Medications in Thai outpatients. J. Med. Ass. Thailand. 68: 229-236

28. Yoovathawon, KC, SRIWATANAKUL, K and Thithapandha, A (1986) Influence of caffeine on aspirin pharmacokinetics. Eur. J.Drug Metab. Pharmacokinet. 11: 71-76

29. Unchern, S, Unchern, S, Chumsawat, P, SRIWATANAKUL, K and Limsuwan, A (1986) Psychomotor performances and subjective feeling studies with antihistamines. J. Med. Association. Thailand. 69: 203-209

30. SRIWATANAKUL, K and Pothisiri, P (1986) Adverse reaction assessment in Thailand. Med. Toxicol. 1(suppl 1): 105-109

31. SRIWATANAKUL, K (1987) Need for chemicals safety information in Thailand. J. Toxicol. Sci. 12: 285-286 [10]

32. Yanapirut, P and SRIWATANAKUL, K (1987) Prospective study of adverse reactions of anticancer Medications in Thai patients. J. Med. Association of Thailand. 70: 448-454

33. SRIWATANAKUL, K (1988) Mechanism of action of anorexiant agents-Amphetamine and other Medications.Medicographia. 10:22-23

34. Critchley, JA, Makarananda, K, Balali-Mood, M. SRIWATANAKUL, K and Lee, MR (1988) Further ethnic differences in the renal dopamine relationship : its uncoupling in the Iranian but not in Thai normotensive subject. J. Hypertension 6(suppl 4): S623-S625  [11]

35. Komindr, S, SRIWATANAKUL, K and Sriwatanakul, K (1988) Double-blind comparison study to determine the efficacy and safety of dexfenfluramine in the treatment of obese patients. Intern. Med. 4: 65-68

36. SRIWATANAKUL, K (1989) Trials of dipyrone in Thailand. Lancet. 1: 788 [12]

37. Critchley, JA, Lee, MR, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Mood, M and Boye, GL (1989) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regionai variation in the prevalence of hypertension? Eur. J. Clin. Pharmacol. 37: 559-562 [13]

38. Critchley, JA, SRIWATANAKUL, K, Charuchinda, C, Balali-Mood, M, Boye. GL, Chan, TY, Brocklesby, NC and Lee MR (1990) Ethnic difference in the renal dopamine response to an oral salt load. J. Human Hypertension. 4: 91-93 [14]

39. Lee, MR, Critchley, JA, Gordon, CJ, Makarananda, K, SRIWATANAKUL, K, Balali-Moods, M and Boye, GL (1990) Ethnic differences in the renal sodium-dopamine relationship : a possible explanation for regional variation in the prevalence of hypertension? Am. J. Hypertension. 3: 100S-103S

40. Prescott, LF, Yoovathaworn, K, Makarananda, K, Saivises, R and SRIWATANAKUL, K (1993) Imparied absorption of paracetamol in vegetarians. Br. J. Clin. Pharmac. 36: 237-240  [15]

41. SRIWATANAKUL, K and Sriwatanakul, K (1995) The efficacy and side effects of antiflatulents in the treatment of functional dyspepsia. Naresuan University J. 3: 1-4

42. Makarananda, K, Pengpan, U, Srisakulthong, M, Yoovathaworn, K and SRIWATANAKUL, K (1998) Monitoring of aflatoxin exposure by biomarkers. J. Toxicol. Sciences 23: (Suppl 11) 155-159

43. Muangman, V, Thithapanda, A Yoovathaworn, K, Supavilai, P, Arunnopparat, W and SRIWATANAKUL, K (1998) A study on diuretic effects of Pluchea indica in man. Thai. J. Urol. 19: 116-128

Published Clinical Citations

[1] ^ Critchley, J A, K Sriwatanakul, C Charuchinda, M Balali-Mood, G L Boye, T Y Chan, N C Brocklesby, and M R Lee. 1990. Ethnic differences in the renal dopamine response to an oral salt load. Journal of human hypertension, no. 2. >

[2] ^ Sriwatanakul, K, K McCormick, and P Woolf. 1984. Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists. The Journal of clinical endocrinology and metabolism, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/6420433

[3] ^ Jeenapongsa, Rattima, Krongtong Yoovathaworn, Kittima M Sriwatanakul, Ubonwan Pongprayoon, and Kampon Sriwatanakul. 2003. Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl) butadiene from Zingiber cassumunar Roxb. Journal of ethnopharmacology, no. 2-3. https://www.ncbi.nlm.nih.gov/pubmed/12860299

[4] ^Makarananda, K, U Pengpan, M Srisakulthong, K Yoovathaworn, and K Sriwatanakul. 1998. Monitoring of aflatoxin exposure by biomarkers. The Journal of toxicological sciences. https://www.ncbi.nlm.nih.gov/pubmed/9760454

[5] ^ McCormick, K, V J Notar-Francesco, and K Sriwatanakul. 1983. Inhibition by acetyl-CoA of hepatic carnitine acyltransferase and fatty acid oxidation. The Biochemical journal, no. 2 ( 15). https://www.ncbi.nlm.nih.gov/pubmed/6661211

[6] ^ Prescott, L F, K Yoovathaworn, K Makarananda, R Saivises, and K Sriwatanakul. 1993. Impaired absorption of paracetamol in vegetarians. British journal of clinical pharmacology, no. 3. https://www.ncbi.nlm.nih.gov/pubmed/9114910.

[7] ^ Sriwatanakul, K. 1987. Need for chemicals safety information in Thailand. The Journal of toxicological sciences, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/3625826

[8] ^ Sriwatanakul, K, W Kelvie, and L Lasagna. 1982. The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trials. Clinical pharmacology and therapeutics, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/7094502

[9] ^ Sriwatanakul, K, L Lasagna, and C Cox. 1983. Evaluation of current clinical trial methodology in analgesimetry based on experts’ opinions and analysis of several analgesic studies. Clinical pharmacology and therapeutics, no. 3. https://www.ncbi.nlm.nih.gov/pubmed/6883903

[10] ^ Sriwatanakul, K, K McCormick, and P Woolf. 1984. Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists. The Journal of clinical endocrinology and metabolism, no. 2. https://www.ncbi.nlm.nih.gov/pubmed/6420433

[11] ^ Sriwatanakul, K, and S R Nahorski. 1980. Disposition and activity of beta-adrenoceptor antagonists in the rat using an ex vivo receptor binding assay. European journal of pharmacology, no. 2-3 ( 29). https://www.ncbi.nlm.nih.gov/pubmed/6108223

[12] ^ Wang, Z X, and K Sriwatanakul. 1983. Medications used for the treatment of dementia. Rational drug therapy, no. 5. https://www.ncbi.nlm.nih.gov/pubmed/6611957

[13] ^ Weintraub, M, K Sriwatanakul, P R Sundaresan, O F Weis, and M Dorn. 1983. Extended-release fenfluramine: patient acceptance and efficacy of evening dosing. Clinical pharmacology and therapeutics, no. 5. https://www.ncbi.nlm.nih.gov/pubmed/6340909

[14] ^ Weis, O, K Sriwatanakul, and M Weintraub. 1982. Treatment of post-herpetic neuralgia and acute herpetic pain with amitriptyline and perphenazine. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, no. 9 ( 21). https://www.ncbi.nlm.nih.gov/pubmed/7112329

[15] ^ Yanapirut, P, and K Sriwatanakul. 1987. Prospective study of adverse reactions of anticancer medications in Thai patients. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, no. 8. https://www.ncbi.nlm.nih.gov/pubmed/3681169.

Private eligibility review

Clarity begins with your medical records.

Send your diagnosis, recent imaging and relevant records. Our clinical team will determine whether a confidential evaluation is appropriate before treatment options are discussed.

Request evaluation
01Send recordsDiagnosis and recent clinical history
02Clinical reviewIndividual suitability assessment
03Next stepsA private response from our team